Добірка наукової літератури з теми "Associations – Patients"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Associations – Patients".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Associations – Patients":

1

Hélaine, Audrey, and Marieke Podevin. "The role of patients’ associations." Bulletin du Cancer 107, no. 3 (March 2020): 381–84. http://dx.doi.org/10.1016/j.bulcan.2019.06.017.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Blanchard, Sandrine. "Le financement des associations de patients." Les Tribunes de la santé 24, no. 3 (2009): 53. http://dx.doi.org/10.3917/seve.024.0053.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Medina, Yves. "Associations de patients et laboratoires pharmaceutiques." Bulletin de l'Académie Nationale de Médecine 199, no. 4-5 (April 2015): 581–87. http://dx.doi.org/10.1016/s0001-4079(19)30933-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Naderan, Mohammad, Saeed Shoar, Farzaneh Rezagholizadeh, Masoome Zolfaghari, and Morteza Naderan. "Characteristics and associations of keratoconus patients." Contact Lens and Anterior Eye 38, no. 3 (June 2015): 199–205. http://dx.doi.org/10.1016/j.clae.2015.01.008.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Prisant, L. Michael. "Carotid Plaque Associations Among Hypertensive Patients." Archives of Internal Medicine 153, no. 4 (February 22, 1993): 501. http://dx.doi.org/10.1001/archinte.1993.00410040067010.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Prisant, L. M. "Carotid plaque associations among hypertensive patients." Archives of Internal Medicine 153, no. 4 (February 22, 1993): 501–6. http://dx.doi.org/10.1001/archinte.153.4.501.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Hanalioglu, Damla, Ann Oh, M’Hamed Temkit, P. David Adelson, and Brian Appavu. "Carbon Dioxide Reactivity of Brain Tissue Oxygenation after Pediatric Traumatic Brain Injury." Children 9, no. 3 (March 14, 2022): 409. http://dx.doi.org/10.3390/children9030409.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Background: We investigated how changes in partial pressure of brain tissue oxygenation (PbtO2) relate to end-tidal carbon dioxide (EtCO2) after pediatric traumatic brain injury (TBI). Methods: Dynamic structural equation modeling (DSEM) was used to investigate associations between EtCO2 and PbtO2, with positive associations indicating intact CO2 reactivity of PbtO2, and negative associations indicating impaired reactivity. Sub-analyses were performed to investigate associations of PbtO2 to intracranial pressure (ICP), arterial blood pressure (ABP) and cerebral regional oximetry (rSO2). Results: Among 14 patients, a positive association between PbtO2 and EtCO2 was demonstrated (SRC 0.05, 95% CI [0.04, 0.06]), with 9 patients demonstrating intact CO2 reactivity and 5 patients demonstrating impaired reactivity. Patients demonstrating intact CO2 reactivity had positive associations between PbtO2 and ICP (0.22 [0.21, 0.23]), whereas patients with impaired reactivity had negative associations (−0.28 [−0.29, −0.28]). Patients demonstrating intact CO2 reactivity had negative associations between PbtO2 and rSO2 (−0.08 [−0.09, −0.08]), whereas patients with impaired reactivity had positive associations (−0.15 [0.14, 0.16]). Compared to patients with intact CO2 reactivity, those with impaired reactivity had increased ICP (p < 0.0000), lower PbtO2 (p < 0.0000) and higher PRx (p = 0.0134). Conclusion: After TBI, CO2 reactivity of PbtO2 can be heterogenous, necessitating further work investigating factors contributing toward impaired reactivity.
8

Hofstede, Stefanie N., Leti van Bodegom-Vos, Dionne S. Kringos, Ewout Steyerberg, and Perla J. Marang-van de Mheen. "Mortality, readmission and length of stay have different relationships using hospital-level versus patient-level data: an example of the ecological fallacy affecting hospital performance indicators." BMJ Quality & Safety 27, no. 6 (October 6, 2017): 474–83. http://dx.doi.org/10.1136/bmjqs-2017-006776.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
BackgroundEcological fallacy refers to an erroneous inference about individuals on the basis of findings for the group to which those individuals belong. Suppose analysis of a large database shows that hospitals with a high proportion of long length of stay (LOS) patients also have higher than average in-hospital mortality. This may prompt efforts to reduce mortality among patients with long LOS. But patients with long LOS may not be the ones at higher risk of death. It may be that hospitals with higher mortality (regardless of LOS) also have more long LOS patients—either because of quality problems on both counts or because of unaccounted differences in case mix. To provide more insight how the ecological fallacy influences the evaluation of hospital performance indicators, we assessed whether hospital-level associations between in-hospital mortality, readmission and long LOS reflect patient-level associations.MethodsPatient admissions from the Dutch National Medical Registration (2007–2012) for specific diseases (stroke, colorectal carcinoma, heart failure, acute myocardial infarction and hip/knee replacements in patients with osteoarthritis) were analysed, as well as all admissions. Logistic regression analysis was used to assess patient-level associations. Pearson correlation coefficients were used to quantify hospital-level associations.ResultsOverall, we observed 2.2% in-hospital mortality, 8.1% readmissions and a mean LOS of 5.9 days among 8 478 884 admissions in 95 hospitals. Of the 10 disease-specific associations tested, 2 were reversed at hospital-level, 3 were consistent and 5 were only significant at either hospital-level or patient-level. A reversed association was found for stroke: patients with long LOS had 58% lower in-hospital mortality (OR 0.42 (95% CI 0.40 to 0.44)), whereas the hospital-level association was reversed (r=0.30, p<0.01). Similar negative patient-level associations were found for each hospital, but LOS varied across hospitals, thereby resulting in a positive hospital-level association. A similar effect was found for long LOS and readmission in patients with heart failure.ConclusionsHospital-level associations did not reflect the same patient-level associations in 7 of 10 associations, and were even reversed in 2 associations. Ecological fallacy thus potentially influences interpretation of hospital performance when patient-level associations are not taken into account.
9

Dourado, E., R. Freitas, P. Martins, L. Saraiva, T. Santiago, F. Guimarães, E. Costa, et al. "AB0696 Prevalence and clinical associations of different autoantibodies in the Reuma.pt systemic sclerosis cohort: is it all really set in stone?" Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1475.2–1476. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3389.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
BackgroundDifferent autoantibodies (Ab) have been associated with distinct systemic sclerosis (SSc) phenotypes. Most of these associations have not been confirmed in Portuguese patients.ObjectivesTo evaluate SSc immuno-clinical associations in the Rheumatic Diseases Portuguese Register (Reuma.pt) cohort.MethodsMulticentre open cohort study including adult SSc patients registered in Reuma.pt up to February 2021. The associations between Ab expression and clinical data were established using Chi-Square, Fischer’s Exact or Mann-Whitney U tests. The Bonferroni correction for multiple comparisons was applied to get α≤0.05. Definite associations were defined by p≤0.002, and likely associations by p≤0.05.Results1080 patients were included, with a mean age and disease duration of 60.2±14.6 and 12.4±10.0 years, respectively. Most were females (87.5%) and had white European ancestry (WEA, 93.2%). The most common disease subtypes were limited cutaneous (lcSSc, 57.4%), diffuse cutaneous (dcSSc, 17.7%), and very early diagnosis of SSc (VEDOSS, 12.3%). Most patients expressed antinuclear Ab (ANA, 93.4%), and the most frequent were anti-centromere (ACA, 54.6%), anti-topoisomerase I (Scl70, 21.8%), and anti-Pm/Scl Ab (PmScl, 4.7%).ACA had definite positive associations with female sex, older age at diagnosis, lcSSc, lower modified Rodnan skin score (mRSS, median 0 vs 4), and isolated sclerodactyly, and likely associations with a higher diagnosis delay, WEA and VEDOSS. ACA had definite inverse associations with flexion contractures (FC), myositis, digital ulcers (DU), and interstitial lung disease (ILD), and likely inverse associations with pitting scars (PS) and oesophageal involvement (OI).Scl70 had definite positive associations with male sex, dcSSc, higher mRSS, FC, DU, PS, ILD, and OI, and likely associations with younger age at diagnosis, tendon friction rubs, active scleroderma pattern in capillaroscopy, and heart involvement.PmScl had a definite association with myositis and likely associations with male sex, calcinosis, joints involvement, and ILD. Anti-U1RNP Ab had definite associations with younger age at diagnosis, MCTD and myositis, and likely associations with a lower diagnosis delay, African ancestry and joint involvement. Anti-RNA polymerase III Ab (RP3) had likely associations with higher mRSS and renal involvement. Anti-U3RNP Ab had a definite association with dcSSc and likely associations with calcinosis and renal involvement. Anti-Th/To Ab had likely associations with male sex and myositis. Anti-Ku Ab had likely associations with systemic lupus erythematosus and mixed connective tissue disease (MCTD) overlap syndromes.ConclusionThere was a higher prevalence of ACA and PmScl compared to other cohorts, most likely due to the high proportion of WEA patients. Most immuno-clinical associations described in the literature apply, including ACA with lcSSc and Scl70 with dcSSc, DU, PS and ILD. However, Scl70+ patients did not have an increased risk of renal involvement, and ACA+ patients did not have an increased risk for calcinosis, PAH or OI, contrary to what was described in the literature. New findings included the association of PmScl with ILD and Scl70 with an active pattern in capillaroscopy. Also, anti-U3RNP+ and Th/To+ patients did not have an increased risk of ILD or PAH, contrarily to what was previously reported. These nuances may be specific to the Portuguese SSc population or signal previously reported associations as geographically specific.Disclosure of InterestsNone declared
10

Amiri, Mina, Fahimeh Tehrani, Razieh Bidhendi-Yarandi, Samira Behboudi-Gandevani, Fereidoun Azizi, and Enrico Carmina. "Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis." Hormone and Metabolic Research 51, no. 01 (January 2019): 22–34. http://dx.doi.org/10.1055/a-0806-8281.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
AbstractWhile several studies have documented an increased risk of metabolic disorders in patients with polycystic ovary syndrome (PCOS), associations between androgenic and metabolic parameters in these patients are unclear. We aimed to investigate the relationships between biochemical markers of hyperandrogenism (HA) and metabolic parameters in women with PCOS. In this systematic review and meta-analysis, a literature search was performed in the PubMed, Scopus, Google Scholar, ScienceDirect, and Web of Science from 2000 to 2018 for assessing androgenic and metabolic parameters in PCOS patients. To assess the relationships between androgenic and metabolic parameters, meta-regression analysis was used. A total number of 33 studies involving 9905 patients with PCOS were included in this analysis. The associations of total testosterone (tT) with metabolic parameters were not significant; after adjustment for age and BMI, we detected associations of this androgen with low-density lipoproteins cholesterol (LDL-C) (β=0.006; 95% CI: 0.002, 0.01), high-density lipoproteins cholesterol (HDL-C) (β=–0.009; 95% CI: –0.02, –0.001), and systolic blood pressure (SBP) (β=–0.01; 95% CI: –0.03, –0.00). We observed a positive significant association between free testosterone (fT) and fasting insulin (β=0.49; 95% CI: 0.05, 0.91); this association remained significant after adjustment for confounders. We also detected a reverse association between fT and HDL-C (β=–0.41; 95% CI: –0.70, –0.12). There was a positive significant association between A4 and TG (β=0.02; 95% CI: 0.00, 0.04) after adjustment for PCOS diagnosis criteria. We also found significant negative associations between A4, TC, and LDL-C. Dehydroepiandrosterone sulfate (DHEAS) had a positive association with LDL-C (β=0.02; 95% CI: 0.001, 0.03) and a reverse significant association with HDL-C (β=–0.03; 95% CI: –0.06, –0.001). This meta-analysis confirmed the associations of some androgenic and metabolic parameters, indicating that measurement of these parameters may be useful for predicting metabolic risk in PCOS patients.

Дисертації з теми "Associations – Patients":

1

Hoff, David. "L'information et la communication autour des maladies respiratoires. De la recherche d'information du malade à la construction sociale d'un champ." Electronic Thesis or Diss., Université de Lorraine, 2012. http://www.theses.fr/2012LORR0370.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Durant les années 80, la prise en charge des personnes insuffisantes respiratoires a bénéficié d'avancées techniques qui ont permis aux malades, auparavant contraints de rester à l'hôpital, de pouvoir retourner chez eux. Les patients ont alors dû faire face à des problèmes auxquels ils n'étaient pas toujours préparés. Atteints d'une pathologie qu'ils ne connaissaient pas, ces derniers ont dû devenir plus autonomes en matière de recherche d'information, de gestion des crises de la maladie et d'utilisation des traitements. Ils devaient comprendre et construire une représentation de leur maladie, très souvent inconnue par leur entourage et par eux-mêmes. Il leur a fallu également affronter le regard des autres et lutter contre la stigmatisation. Progressivement, les patients se sont réunis et ont créé des associations dans le but de faire face ensemble à ces problématiques. Ces associations départementales ou régionales se sont rapidement fédérées pour former une organisation d'échelle nationale, la Fédération Française des Associations et Amicales de malades Insuffisants ou handicapés Respiratoires (FFAAIR). Progressivement, ce mouvement a permis à des agents d'acquérir la légitimité de représenter les malades et de participer avec les professionnels de santé à la construction d'un nouveau champ social. Ces transformations ont été accompagnées et rendues possibles par l'émergence d'une nouvelle forme d'engagement socio-discursif associatif
During the 1980's, the management and treatment of people suffering from respiratory failure has been improved by new technical developments enabling patients to return home instead of staying in hospital. These patients were thus confronted by certain issues that they were not necessarily prepared for. Diagnosed with a pathology that they did not know, they had to become more self-reliant in terms of information research, health crisis management and the use of medical treatment. They had to understand and build a representation of their disease, a disease often unknown to their family/social circle as well as themselves. They also had to face the regard of others and to fight against stigmatization. The patients thus joined together and created associations in order to address, together, such problems. These departmental or regional associations soon became an organization on a national scale, the Fédération Française des Associations et Amicales de malades Insuffisants ou handicaps Respiratoires (FFAAIR). Progressively, this movement enabled agents to gain legitimacy in representing patients and, together with health professionals, take part in the construction of a new social field. Such transformations were supported and made possible by the emergence of a new form of socio-discursive associative commitment
2

Edwards, Laura Jane Rhianwen. "Molecular Genetic Associations with Psychological Morbidity in Cancer Patients." Thesis, University of Leeds, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.485238.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Hoff, David. "L'information et la communication autour des maladies respiratoires. De la recherche d'information du malade à la construction sociale d'un champ." Thesis, Université de Lorraine, 2012. http://www.theses.fr/2012LORR0370/document.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Durant les années 80, la prise en charge des personnes insuffisantes respiratoires a bénéficié d'avancées techniques qui ont permis aux malades, auparavant contraints de rester à l'hôpital, de pouvoir retourner chez eux. Les patients ont alors dû faire face à des problèmes auxquels ils n'étaient pas toujours préparés. Atteints d'une pathologie qu'ils ne connaissaient pas, ces derniers ont dû devenir plus autonomes en matière de recherche d'information, de gestion des crises de la maladie et d'utilisation des traitements. Ils devaient comprendre et construire une représentation de leur maladie, très souvent inconnue par leur entourage et par eux-mêmes. Il leur a fallu également affronter le regard des autres et lutter contre la stigmatisation. Progressivement, les patients se sont réunis et ont créé des associations dans le but de faire face ensemble à ces problématiques. Ces associations départementales ou régionales se sont rapidement fédérées pour former une organisation d'échelle nationale, la Fédération Française des Associations et Amicales de malades Insuffisants ou handicapés Respiratoires (FFAAIR). Progressivement, ce mouvement a permis à des agents d'acquérir la légitimité de représenter les malades et de participer avec les professionnels de santé à la construction d'un nouveau champ social. Ces transformations ont été accompagnées et rendues possibles par l'émergence d'une nouvelle forme d'engagement socio-discursif associatif
During the 1980's, the management and treatment of people suffering from respiratory failure has been improved by new technical developments enabling patients to return home instead of staying in hospital. These patients were thus confronted by certain issues that they were not necessarily prepared for. Diagnosed with a pathology that they did not know, they had to become more self-reliant in terms of information research, health crisis management and the use of medical treatment. They had to understand and build a representation of their disease, a disease often unknown to their family/social circle as well as themselves. They also had to face the regard of others and to fight against stigmatization. The patients thus joined together and created associations in order to address, together, such problems. These departmental or regional associations soon became an organization on a national scale, the Fédération Française des Associations et Amicales de malades Insuffisants ou handicaps Respiratoires (FFAAIR). Progressively, this movement enabled agents to gain legitimacy in representing patients and, together with health professionals, take part in the construction of a new social field. Such transformations were supported and made possible by the emergence of a new form of socio-discursive associative commitment
4

Pereira, Filipa Alexandra Antunes Vences de Matos. "Patient associations: raising awareness on chronic diseases." Master's thesis, Universidade de Aveiro, 2015. http://hdl.handle.net/10773/16582.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Mestrado em Biomedicina Farmacêutica
The patient associations assume a significant role in representing the patients’ rights, sharing information on the diseases, accessing the available resources, maintaining important interactions with other relevant stakeholders and facing challenges. These organizations provide an important support not only to the patients, but also to their families and friends, who are most of the times their direct caregivers. Currently, the patient empowerment has been highly discussed. This project aims to demonstrate in five different clinical disorders what are the motivations, the objectives, the activities, the involvement with other stakeholders and the challenges assumed by the correspondent patient associations. The result of this project allowed to conclude that the significant prevalence of chronic diseases has been introducing changes into the healthcare systems and national disease programmes. Simultaneously, the patients’ ownership has been increasing, contributing to a more participated role near the healthcare professionals and to a more conscious decision regarding the available therapeutics. Patient associations represent these patients and act in critical areas, such as, social, clinical, research, training, education and advocacy.
As associações de doentes assumem um papel fundamental na representação dos direitos dos pacientes, na divulgação de informação acerca das doenças, no acesso aos recursos disponíveis, no relacionamento com os vários intermediários e nos desafios a enfrentar. Estas associações prestam não só um grande apoio aos doentes, como também aos seus familiares e amigos, que são na maior parte das vezes os seus cuidadores diretos. Atualmente, a capacitação de doentes tem vindo a ser bastante discutida. Este projeto pretende demonstrar em cinco quadros clínicos distintos, quais as motivações presentes, os objetivos, as atividades realizadas, o envolvimento com outros stakeholders e os desafios enfrentados pelas respetivas associações de doentes. O resultado deste trabalho permitiu concluir que a prevalência significativa de doenças crónicas tem introduzido alterações nos sistemas de saúde e nos planos nacionais de doenças. Em simultâneo, a responsabilidade dos pacientes tem vindo a aumentar, contribuindo para um posicionamento cada vez mais participativo junto dos profissionais de saúde e para uma tomada de decisão mais consciente em relação às terapêuticas disponíveis. As associações de doentes dão voz a estes pacientes e atuam em áreas críticas, tais como, a área social, emocional, clínica, de investigação, de formação, de educação e de defesa e representatividade de direitos e benefícios.
5

Simonpietri, Caroline. "Acquisition et circulation du savoir « profane » et médical pour la prise en charge des maladies chroniques, en France, à l'essor du numérique et de la « démocratie sanitaire »." Thesis, Sorbonne Paris Cité, 2017. http://www.theses.fr/2017USPCB180/document.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Dans le cadre d'une convention CIFRE, ce travail de thèse porte sur l'acquisition et la circulation d'un savoir "profane" et médical pour la prise en charge des maladies chroniques. Sous la direction de Dominique Desjeux, Professeur émérite, expert en consommation et innovation, nous avons analysé le processus de diffusion de trois "innovations" du système de santé français portées par les institutions depuis le début du 21ème siècle : les associations de patients, l’Éducation Thérapeutique du Patient (ETP), et enfin les NTIC, et plus précisément les serious games. Respectivement sociale, symbolique et matérielle, ces trois solutions ont pour enjeu institutionnel diminuer les coûts de santé en améliorant l'apprentissage de vie des patients avec leur maladie mais également celui des professionnels de santé en formation initiale et continue. Pour chaque solution, dans une démarche qualitative, compréhensive et inductive, nous nous sommes interrogés sur les rugosités pouvant freiner leur réception par l'usager final, des patients ou des médecins. Avec un angle de vue assez original, un regard "socio-anthropologique" au coeur du secteur industriel, nous avons finalement reconstruit une partie du système d'action impliqué dans la circulation de savoirs en santé, profane et médical en cette période de crise sanitaire et d'explosion technologique
Within the framework of a "CIFRE convention, this work concerns the acquisition and the circulation of a " lay" and medical knowledge for the care of people who suffer from chronic diseases. Supervised by Dominique Desjeux, emeritus Professor, specialised in consumption and innovation, we have analyzed the diffusion process of three "innovations" of the French health system since the beginning of the 21th century: patients' associations, Therapeutic Education, and finally the ICT, and more exactly the serious games. Respectively social, symbolic and material, these three solutions have, for institutional issues, to decrease the costs of health care and management, by improving the "apprenticeship of life with disease" of patients, but also the professionnals trainning, initial as continuous. For each solution, in a qualitative, comprehensive and inductive approach, we wondered about the roughnesses which can slow down their "reception" by the final user, the patients or the doctors. With a rather original viewpoint, a "socio-anthropological" look at the heart of the branch of occidental industry, we finally reconstructed a part of the "action system" (Crozier, 1963) involved in the circulation of knowledges in health, from patients or medical way, in this transitory period of sanitary crisis and technological explosion
6

Wallis, Lauren Ingrid. "Memory for items and associations in amnesiac patients and controls." Thesis, University of Sheffield, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.274958.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Koo, Minjoung Monica Koo. "The presenting symptoms of cancer patients and associations with diagnostic timeliness." Thesis, University College London (University of London), 2018. http://discovery.ucl.ac.uk/10053161/.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Diagnosing cancer earlier is an important strand of cancer control. Interventions promoting early diagnosis such as awareness campaigns and fast-track clinical pathways are increasingly commonplace in England and other countries, but their theoretical underpinning is limited. Cancer symptoms are critical components of such interventions, but evidence regarding the presenting symptoms of individuals diagnosed with cancer and measures of diagnostic timeliness remains sparse. I sought to address this evidential gap using data from the first English National Audit of Cancer Diagnosis in Primary Care on a large and representative cohort of cancer patients. Using symptom status (ascertained through the coding of free-text information on presenting symptoms), I identified and described a group of atypically diagnosed cancer patients before proceeding to examine the nature and frequency of presenting symptoms and associated diagnostic timeliness among symptomatic cancer patients. I profiled the broad range of presenting symptoms beyond breast lump among women diagnosed with breast cancer, and found that non-lump symptoms were associated with longer intervals to presentation and referral. I also described variation in diagnostic timeliness among cancer patients who presented with abdominal symptoms, and the case-mix of cancers they were subsequently diagnosed with. The relative length of time to presentation and referral varied by abdominal symptom. A considerable proportion of cancer patients who presented with abdominal symptoms were diagnosed with other solid tumours or haematological cancers, particularly for non-specific abdominal symptoms. Lastly, I examined the association between alarm symptoms and stage at diagnosis among cancer patients who had presented promptly. While most alarm symptoms at presentation were associated with early stage disease, the extent of the association was highly variable compared to patients with other symptomatic presentations. This thesis provides exemplar evidence regarding the epidemiology of presenting symptoms among cancer patients and associated diagnostic timeliness. Together with other evidence, the findings could contribute to the design and evaluation of symptom awareness campaigns and healthcare interventions that expedite the investigation and diagnosis of cancer.
8

Brüggemann, A. Jelmer, and Katarina Swahnberg. "Patients’ silence towards the healthcare system after ethical transgressions by staff : associations with patient characteristics in a cross-sectional study among Swedish female patients." Linköpings universitet, Institutionen för klinisk och experimentell medicin, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-90217.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Objectives To identify which patient characteristics are associated with silence towards the healthcare system after experiences of abusive or ethically wrongful transgressive behaviour by healthcare staff. Design Cross-sectional questionnaire study using the Transgressions of Ethical Principles in Health Care Questionnaire. Setting A women's clinic in the south of Sweden. Participants Selection criteria were: consecutive female patients coming for an outpatient appointment, ≥18-year-old, with the ability to speak and understand the Swedish language, and a known address. Questionnaires were answered by 534 women (60%) who had visited the clinic, of which 293 were included in the present study sample. Primary outcome measure How many times the respondent remained silent towards the healthcare system relative to the number of times the respondent spoke up. Results Associations were found between patients’ silence towards the healthcare system and young age as well as lower self-rated knowledge of patient rights. Both variables showed independent effects on patients’ silence in a multivariate model. No associations were found with social status, country of birth, health or other abuse. Conclusions The results offer opportunities for designing interventions to stimulate patients to speak up and open up the clinical climate, for which the responsibility lies in the hands of staff; but more research is needed.

Funding Agencies|Swedish Research Council|2009-2380|Nordic Council of Ministers||

9

Barbot, Janine. "Recherche médicale et mobilisations collectives : le cas des associations de lutte contre le sida." Paris, EHESS, 2000. http://www.theses.fr/2000EHES0039.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Burleigh, Karen Sarita. "Associations among plasma homocysteine, amino acids and nutritional status in hemodialysis patients." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 2001. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp05/MQ63163.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Книги з теми "Associations – Patients":

1

Baggott, Rob. Speaking for patients and carers: Health consumer groups and the policy process. Houndmills, Basingstoke, Hampshire: Palgrave Macmillan, 2005.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Wood, Bruce. The politics of disease-related patients' associations: An Anglo-American comparison. Manchester: Department of Government, University of Manchester, 1999.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Burleigh, Karen Sarita. Associations among plasma homocysteine, amino acids and nutritional status in hemodialysis patients. Ottawa: National Library of Canada, 2001.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

United States. Agency for International Development., International Community of Women living with HIV/AIDS., Global Network of People Living with HIV/AIDS., and Synergy Project, eds. Directory of associations of people living with HIV/AIDS. 2nd ed. Washington, D.C: Social & Scientific Systems under The Synergy Project, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Matos, Ana Raquel, and Mauro Serapioni. Saúde, participação e cidadania: Experiências do sul da Europa. Coimbra: CES, 2014.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Shumar, Erik. Associations between Homelessness and Psychiatric Symptom Severity and How Homelessness Interacts with Risk Factors among First-Admission Psychiatric Patients. [New York, N.Y.?]: [publisher not identified], 2014.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Roscher, Roland. Der Beitrag der Freien Wohlfahrtspflege zum Gemeinwohl am Beispiel der Suchtkrankenhilfe. Baden-Baden: Nomos, 1999.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Consortium of Christian Relief & Development Associations (Ethiopia). CCRDA HIV/AIDS members' directory. Addis Ababa, Ethiopia: Consortium of Christian Relief and Development Association (CCRDA), 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Perry, Angela. American Medical Association guide to talking to your doctor. New York: Wiley, 2001.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

McKibben, Sherry A. Daunting tasks, dedicated people: Stories in the management of change in HIV/AIDS organizations. Edmonton: Muttart Foundation, 2001.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "Associations – Patients":

1

Roberts, John D., and Mick J. Mason. "Coping With FAP The Roll of Patients’ Associations." In Intestinal Polyps and Polyposis, 235–41. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-1124-3_23.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Moule, Alex J., and M. Lamar Hicks. "Analyzing Patients in Pain - Associations with Cold and Heat." In Diagnosing Dental and Orofacial Pain, 36–40. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781119155218.ch7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Albano, Domenico, Francesco Dondi, Pietro Bellini, and Francesco Bertagna. "Biomarkers and Molecular Imaging in Postoperative DTC Management." In Integrated Diagnostics and Theranostics of Thyroid Diseases, 129–42. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-35213-3_8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
AbstractThe standard of care for differentiated thyroid carcinoma (DTC) includes surgery, risk-adapted postoperative radioiodine [iodine-131 (131I)] therapy, individualized thyroid hormone therapy, and follow-up for detection of patients with recurrent or persistent disease.Recently, several international associations like ATA, EANM, and SNMMI developed specific guidelines for the management of these patients. They shared that an individualized risk-adapted approach should be suggested considering the main clinical, epidemiological, and histopathological features. The postoperative management of DTC is a challenge because several biomarkers and molecular imaging tools are available. The choice of execution and the timing of neck ultrasound, serum anti-thyroglobulin antibody and basal/stimulated thyroglobulin, the 131I/123I diagnostic whole-body scans integrated by single photon emission computed tomography/computed tomography (SPECT/CT) if indicated, and 18F-fluorodeoxyglucose ([18F]-FDG) positron emission tomography/CT (PET/CT) is directly related to the patients’ characteristics. In this chapter, we summarize the role of the main biomarker and molecular imaging examinations in the management of DTC patients in postoperative setting.
4

Blanco, Ignacio. "Registries and Patients’ Associations." In Blanco's Overview of Alpha-1 Antitrypsin Deficiency, 193–206. Elsevier, 2017. http://dx.doi.org/10.1016/b978-0-12-809530-0.00014-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Laffont, J. Y. "Associations de Patients en Médecine Vasculaire." In Traité de médecine vasculaire., 853–59. Elsevier, 2011. http://dx.doi.org/10.1016/b978-2-294-71346-0.50041-0.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Joly, A. S. "Associations de patients en situation d'obésité." In Les Obésités, 503–7. Elsevier, 2021. http://dx.doi.org/10.1016/b978-2-294-76753-1.00089-8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Vanderheyden, Jean-Émile, and Dominique-Jean Bouilliez. "Associations de patients en Belgique et en Francophonie." In Traiter le Parkinson, 401. De Boeck Supérieur, 2010. http://dx.doi.org/10.3917/dbu.vande.2004.01.0401.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Dunlay, Shannon M. "Frailty: Assessment and Associations with Outcomes." In Mechanical Circulatory Support, 16–22. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780190909291.003.0003.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Frailty is a syndrome of decreased physiological reserve in response to stressors, which increases the vulnerability to adverse health outcomes. Although there is no standard reference test for detecting frailty before left ventricular assist device (LVAD) implantation, several screening tools can be helpful. Numerous studies have found that frailty is often present in patients scheduled to receive LVADs and is associated with longer and more complicated post-implant hospitalizations and worse long-term mortality. Contemporary data suggest that frailty is at least partially reversible with LVAD therapy in some individuals. New therapeutic strategies to improve or reverse frailty in patients receiving LVADs are needed.
9

Wallace, Daniel J. "Differential diagnosis and disease associations." In Lupus The Essential Clinician’s Guide, 55–58. Oxford University PressNew York, NY, 2008. http://dx.doi.org/10.1093/oso/9780195368987.003.0008.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Abstract Lupus has many similarities to the “great mimicker,” as Sir William Osler termed syphilis. It can present with symptoms, signs, and laboratory abnormalities affecting every organ system in the body. Twenty percent of patients with one autoimmune disease (including lupus) have a second autoimmune disorder. As a result, there is often a great degree of confusion when lupus is part of the differential diagnosis. This chapter addresses these issues.
10

Kashyap, Ramgopal. "Miracles of Healthcare With Internet of Things." In Smart Devices, Applications, and Protocols for the IoT, 120–64. IGI Global, 2019. http://dx.doi.org/10.4018/978-1-5225-7811-6.ch007.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Today, IoT in therapeutic administrations has ended up being more productive in light of the fact that the correspondence among authorities and patients has been improved with versatile applications. These applications are made by the associations with the objective that the pros can screen the patient's prosperity. If any issue has hopped out at the patient, the authority approaches the patient and gives the correct treatment. In this proposition, particular focus is given to infant human administrations, in light of the fact that the greatest fear of gatekeepers is that they would lose their infant kids at whatever point. Therefore, a business contraption has been recognized which screens consistent information about the infant's heart rate, oxygen levels, resting position. In case anything happens to the infant, the information will get to the adaptable application which has been made by an association and is mechanically available by finishing a representation field test for the kid.

Тези доповідей конференцій з теми "Associations – Patients":

1

"O-007 - PRESCRIPTION PATTERNS ON PATIENTS WITH DUAL DIAGNOSIS: A RETROSPECTIVE INPATIENT ANALYSIS." In 24 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL. SEPD, 2022. http://dx.doi.org/10.17579/abstractbooksepd2022.o007.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Introduction. Dual diagnosis (DD) refers to the simultaneous diagnosis of a psychiatric disorder and a substance use disorder (SUD). The prevalence rate is considerably high in patients with schizophrenia and affective disorders; it predicts a more severe illness course, with decreased adherence to treatment and higher rates of hospitalization. As such, there is a growing demand for clinical guidelines and treatment consensus for these patients. In this retrospective analysis, we aimed to examine if and how prescription patterns in DD differ regarding psychiatric diagnosis and type of substance used. Methods. Data from patients with a DD diagnosis admitted at Lisbon’s Psychiatric Hospital Center from June to September 2021 was collected (n=94). Chi-square or Fisher tests were used to analyze associations between substance use and specific psychiatric disorders, along with number and class of medications prescribed. Results. Schizophrenia was the most frequent diagnosis (n=47). The most abused substances were alcohol (n=62) and cannabinoids (n=57). We found a statistically significant association between schizophrenia and cannabis misuse (p=0,006). A personality disorder diagnosis was also found to be associated to the misuse of cannabinoids (p=0,04) and cocaine (p=0,003). Finally, there was a statistically significant association between prescription of 2 or more drugs from different classes and a diagnosis of schizophrenia. No association was found between number/class of drugs, other psychiatric conditions or the type of substance misuse. Conclusion. Our study confirms well established associations between specific substance use and psychiatric conditions. However, no evidence of a specific drug prescription pattern of use in DD patient was apparent, which suggests the need for more studies on DD population and treatment outcomes.
2

Sikorová, Kateřina, Veronika Zizková, Lenka Kocourková, Adam Strnad, Martina Doubková, Martin Petrek, and Martin Petřek. "HLA Associations in Czech Patients with Sarcoidosis." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa702.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Sam, Ashley E., Zachary Weber, Alejandra Pena, Lauren Ryder, Cody Henderson, Donald McCurnin, Utpal S. Bhalala, Rogelio Garcia, Jonathan M. King, and Nicholas R. Carr. "Clinical Associations in Pediatric ECLS patients with Elevated Iron Markers." In AAP National Conference & Exhibition Meeting Abstracts. American Academy of Pediatrics, 2021. http://dx.doi.org/10.1542/peds.147.3_meetingabstract.425-a.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Salimbene, O., I. Salimbene, M. C. Zanetti, M. Ravina, and D. Panepinto. "Associations of black carbon with lung function in COPD patients." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.2026.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Qureshi, Hanya M., Joanna Tabor, Joseph O’Brien, Haoyi Lei, Sagar Vasandani, Muhammad Jalal, Shaurey Vetsa, et al. "Associations of Frailty with Longitudinal Outcomes in Patients with Meningiomas." In 32nd Annual Meeting North American Skull Base Society. Georg Thieme Verlag KG, 2023. http://dx.doi.org/10.1055/s-0043-1762354.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Kim, S. E., K. F. Gibson, D. Kass, M. Broerman, Y. Zhang, M. Nouraie, and G. C. Goobie. "PM2.5 Associations With Lung Function in Patients With Pulmonary Sarcoidosis." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6633.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Lenferink, Anke, Job van der Palen, Peter Frith, Paul van der Valk, and Tanja Effing. "Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa3756.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sobral Rebelo, Patrícia Filipa, Ana Oliveira, Cátia Paixão, Sara Souto-Miranda, Ana Machado, Ana Alves, Joana Cruz, et al. "Unravelling associations between fatigue and key outcomes in patients with COPD." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.2459.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Znegui, Tasnim, Moussa Nadia, Nour Mahmoud, Kotti Amina, Kallel Nesrin, Gargouri Rahma, Bahloul Najla, et al. "Associations between comorbidities and survival in patients with interstitial lung diseases." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa2342.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Batlle, J., M. F. López-Fernández, C. López-Berges, R. Sánchez, L. G. Villarón, and T. S. Zimmerman. "VON WILLEBRAND'S DISEASE TYPE IIB ASSOCIATED TO A COMPLEX THROMBOCYTOPENIC THROMBOCYTOPATHY." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644642.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
A family bleeding disorder characterized by a new association between Type IIB von Willebrand's disease (vWD) and a complex platelet disfunction, with an intermittent thrombocytopenia is described in two patients from the same generation. The mother and a maternal aunt died having severe bleeding diathesis. The platelet abnormalities included: borderline or slightly low platelet count but moderate thrombocytopenia coincedent with the acute bleeding episodes, giant platelet site with a very heterogeneous distribution width, large number of vesicles in platelets by electron-microscopy recalling the "Swiss-Cheese" platelets, abnormal platelet aggregation induced by ADP, collagen, epinephrin and slightly, by thrombin, defective release of 14C-Serotonin, von Willebrand factor (vWF) and platelet factor 4 induced by thrombin or ADP. DDAVP was given to both patient and a partial and transitory correction of bleeding time, thrombocytopenia, presence of platelet aggregates on smear besides a brief appearence of larger multimers of vWF and an increase in all Factor VIII/von Willebrand Factor (FVIII/vWF) properties were seen. Binding of labeled vWF using radiolabelled monoclonal anti-vWF antibody showed an enhanced binding of the patients' vWF, induced by ristocetin, to either normal or patients' platelets. In contrast, the binding of labeled purified normal vWF induced by thrombin to patients' platelets was decreased as compared with the correspondent control. Thus, both patients have platelet disfunctions characteristic for more than one specific platelet disorder. Several associations between platelet and FVIII/vWF abnormalities have been described. This is the first family presenting association of Type IIB vWD and a complex thrombocytopathy. The inherited or acquired (induced by the abnormal IIB vWF platelet interaction) nature of the abnormality is discussed.

Звіти організацій з теми "Associations – Patients":

1

Alves-Nogueira, Ana Cláudia, Ana Carolina Góis, Maria Cristina Canavarro, Cláudia Melo, and Carlos Carona. Examining the associations between physician-patient communication and adjustment outcomes of patients and physicians: A systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2022. http://dx.doi.org/10.37766/inplasy2022.6.0062.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: The aims of this systematic review are: first, to critically synthesize current evidence for the associations between physician-patient communication (PPC) and patients’ adjustment outcomes; second, to analyse and describe the associations reported to date between PPC and physicians' adjustment outcomes; and third, to identify needs for future research on the outcomes and correlates of PPC. To this end, the proposed systematic review will address the following question: How is PPC related to patients' and physicians' adjustment outcomes? Information sources: Literature systematic search will be conducted on the following electronic databases: PubMed/Medline, PsycINFO (host: OVID), Embase (host: OVID), SocIndex (host: EBSCO) and Communication Source (host: EBSCO). References cited in articles and in previous systematic reviews will also be further reviewed to locate any additional relevant articles that may have not been retrieved within the primary search.
2

Li, Peng, and Junjun Liu. Effect of tumor necrosis factor inhibitors on the risk of adverse cardiovascular events in patients with psoriasis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0090.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: Previous studies have indicated a cardioprotective effect of tumor necrosis factor inhibitor (TNFi) therapy in adult patients with psoriasis (Pso). However, most were retrospective studies, and the association between cardiometabolic comorbidities and major adverse cardiovascular events (MACE) has not been validated in randomized controlled trials (RCTs). Condition being studied: Because the available evidence has recently increased, we performed the present updated meta-analysis and meta-regression of cohort studies and RCTs to evaluate whether TNFi therapy can decrease the risk of MACE among patients with Pso and to assess the associations between cardiometabolic comorbidities and MACE.
3

Li, Tian, and Min Sun. Associations between hepatectomy and survival of gastric cancer patients with liver metastases: A network pooling analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2020. http://dx.doi.org/10.37766/inplasy2020.12.0009.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Xiao, Youchao, Wentao Wu, Lu Jin, Yanfei Jia, Kefan Cai, Ning Qiao, Lei Cao, and Songbai Gui. Association between radiotherapy and follow-up obesity in craniopharyngioma: a mini-review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2022. http://dx.doi.org/10.37766/inplasy2022.12.0008.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: The effect of radiotherapy on post-treatment weight is incompletely defined. We determined the associations between radiotherapy and follow-up obesity in patients with craniopharyngioma (CP). Eligibility criteria: The inclusion criteria were as follows: (1) Participants: Patients who were clinically diagnosed with craniopharyngioma; (2) Intervention/control: For the control group, patients have not received radiotherapy, and the patients of the intervention group received radiotherapy alone, or surgery combined radiotherapy, or radiotherapy combined adjuvant therapy; (3) Outcome: The outcome was postoperative BMI or postoperative obesity. We excluded studies with (1) in vitro or animal experiments; (2) not written in English; (3) conference abstracts, reviews, correspondence, and comments; (4) case reports that included less than 10 patients.
5

Lee, Hee Jin, Min Cheol Chang, Yoo Jin Choo, and Sae Yoon Kim. The Associations between Headache (Migraine and Tension-type Headache) and Psychotic Symptoms (Depression and Anxiety) in Pediatrics: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2022. http://dx.doi.org/10.37766/inplasy2022.10.0078.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: The purpose of this study was to investigate the association with specific psychiatric symptoms such as depression and anxiety in pediatric patients suffering from migraine and TTH. In our meta-analysis for a detailed evaluation of depression and anxiety, we attempted to review the research using various psychodiagnostic tools. Eligibility criteria: The detailed inclusion criteria for the network meta-analysis were studies with (1) inclusion of pediatric patients; (2) patients with migraine and TTH; (3) evaluation of association between headache (migraine or TTH) and psychotic symptoms (depression and anxiety); (4) comparison between group with headache (migraine or TTH) and control group; (5) using tools for evaluating degree of depression or anxiety; and (6) written in English. Review articles, case reports, letters, and studies with insufficient data or results were excluded.
6

Lu, Shuai, Zhenpeng Yang, Huazhen Tang, Xibo Sun, Bing Wang, Jinxiu Qu, Yuying Wang, and Benqiang Rao. Associations between omega-3 polyunsaturated fatty acids supplementation and surgical prognosis in patients with gastrointestinal cancer : a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0007.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Gao, Jiang-Ping, Wei Guo, and Hong-Peng Zhang. Prevalence and Prognostic Associations of Early Postoperative Stroke and Death among Patients Undergoing Inner Branched Thoracic Endovascular Repair of Aortic Arch Pathologies: A systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0010.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Review question / Objective: To assess the prevalence and associations of early postoperative stroke and death among patients undergoing inner branched thoracic endovascular aortic repair (TEVAR) of arch pathologies. Eligibility criteria: Our including criteria are as follows: 1) Patients with aortic arch pathologies, who were judged unfit for open surgery in a multidisciplinary path; 2) using inner branched TEVAR for the endovascular repair. 3) report the prevalence of 30-day postoperative stroke or death as result. Excluding criteria: 1) combined with fenestration or chimney in TEVAR; 2) full-text unavailable; 2) case reports with fewer than three cases; 3) studies with an only reconstruction of the left subclavian artery (LSA) rather than innominate artery or left common carotid artery (LCCA).
8

Zhang, Yu, Chaoliang Sun, Hengxi Xu, Weiyang Shi, Luqi Cheng, Alain Dagher, Yuanchao Zhang, and Tianzi Jiang. Connectivity-Based Subtyping of De Novo Parkinson Disease: Biomarkers, Medication Effects and Longitudinal Progression. Progress in Neurobiology, April 2024. http://dx.doi.org/10.60124/j.pneuro.2024.10.04.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Parkinson's disease (PD) is characterized by divergent clinical symptoms and prognosis, suggesting the presence of distinct subtypes. Identifying these subtypes is crucial for understanding the underlying pathophysiology, predicting disease progression, and developing personalized treatments. In this study, we propose a connectivity-based subtyping approach, which measures each patient's deviation from the reference structural covariance networks established in healthy controls. Using data from the Parkinson's Progression Markers Initiative, we identified two distinct subtypes of de novo PD patients: 248 patients with typical cortical-striato-thalamic dysfunctions and 41 patients showing weakened dorsal raphe nucleus (DRN)-to-cortical/striatal projections. The proposed subtyping approach demonstrated high stability in terms of random sampling of healthy or diseased population and longitudinal prediction at follow-up visits, outperforming the traditional motor phenotypes. Compared to the typical PD, patients with the DRN-predominant subtype were characterized by less server motor symptoms at baseline and distinct imaging biomarkers, including larger striatal volumes, higher concentration of cerebrospinal fluid amyloid-β and amyloid-β/t(p)-tau ratio. Subtype-specific associations and drug effects were identified that the DRN subtype exhibited more pronounced medication effects on motor symptoms, potentially regulated by DRN serotonergic modulation through striatal dopaminergic neurons. The DRN serotonergic inputs also regulated non-motor symptoms, the aggregation of CSF biomarkers and the conversion to more severe disease states. Our findings suggest that the DRN-predominant subtype represents a unique clinical and biological phenotype of PD characterized by an enhanced response to anti-parkinsonian treatment, more favorable prognosis and slower progression of dopamine depletion. This study may contribute to clinical practice of precision medicine, early invention and individualized treatments in PD and other neurodegenerative diseases.
9

Woods, Rachel, Alison Zhong, and Madelyn Vincent. Factors Associated with Influenza & Tdap Vaccine Uptake in Pregnant Patients at the UT Family Medicine Clinic in Memphis. University of Tennessee Health Science Center, 2021. http://dx.doi.org/10.21007/com.lsp.2020.0003.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
INTRODUCTION: Given the increased risk for infections among pregnant patients and newborns, vaccination against influenza (>50,000,000 annual US cases affecting all ages) and pertussis (>15,000 annual US cases disproportionately affecting newborns) are recommended among pregnant patients in order to protect them and their babies via passive immunity to cover a newborn’s window of vaccine ineligibility. Though flu and Tdap vaccination rates among pregnant patients have been trending upwards nationally, there is still room for improvement to achieve optimal rates. OBJECTIVES: The primary objectives were to study factors that affect the vaccination rates at the University of Tennessee Family Medicine Clinic at Memphis (UTFMC-M), compare those rates with national pregnancy flu/Tdap vaccination rates, and to generate recommendations based off observed factors associated with vaccine uptake to improve flu/Tdap vaccination rates in UTFMC-M pregnant patients. METHODS: This was a retrospective chart review of UTFMC-M patients who were pregnant from September 1, 2019-April 24, 2020 (included 2019-2020 flu season) (n=465). Variables studied included demographic data (race, age, insurance), immunization history (vaccine status, history of physician encouragement), and prenatal history (parity, number of prenatal visits, trimester at first visit, high risk clinic (HRC) admittance status). Vaccination status was based on ACIP recommendations (Flu shot eligible = any gestational age; Tdap eligible = ≥27 weeks). Positive HRC admittance was noted for patients with ≥2 visits to the UTFMC-M HRC, a clinic that specializes in high risk pregnant patient care. RESULTS: The patient sample was predominantly black (84.3%) and insured by Medicaid programs (88%). Among eligible UTFMC-M pregnant patients, 50.1% were flu-vaccinated (n=465); 73.8% were Tdap-vaccinated (n=317); and 52.1% were Flu+Tdap-vaccinated (n=317). No significant associations were found between vaccine uptake and HRC status, parity, and age. However, statistically significant relationships were found between vaccine uptake and physician encouragement (positive relationship with flu shot: X2(1, N = 465) =131, p < 0.001, Tdap: X2 (6, N = 465) =476, p < 0.001), number of prenatal visits (flu shot group median 8 visits, Tdap group median 9 visits vs. unvaccinated group median 4 visits; p < 0.001), and early trimester age at first prenatal visit (X2(6, N = 465) =47.635 , p CONCLUSION: 2019-2020 UTFMC-M vaccination rates were on par with 2018-2019 US flu vaccine rates and higher than 2018-2019 US Tdap and Flu+Tdap rates. There were statistically significant relationships between vaccine uptake at UTFMC-M and physician encouragement, number of prenatal visits, and early trimester age at first prenatal visit but no significant relationships with UTFMC-M HRC admittance, parity, or age. Recommendations following from our observations to address further vaccine rate improvement include: continue vaccine encouragement, continue booking multiple visits (8 for flu, 9 for Tdap), prioritize Tdap vaccine higher for late trimester intake patients, and focus on flu vaccine encouragement and education.
10

James-Scott, Alisha, Rachel Savoy, Donna Lynch-Smith, and tracy McClinton. Impact of Central Line Bundle Care on Reduction of Central Line Associated-Infections: A Scoping Review. University of Tennessee Health Science Center, November 2021. http://dx.doi.org/10.21007/con.dnp.2021.0014.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Purpose/Background Central venous catheters (CVC) are typical for critically ill patients in the intensive care unit (ICU). Due to the invasiveness of this procedure, there is a high risk for central line-associated bloodstream infection (CLABSI). These infections have been known to increase mortality and morbidity, medical costs, and reduce hospital reimbursements. Evidenced-based interventions were grouped to assemble a central line bundle to decrease the number of CLABSIs and improve patient outcomes. This scoping review will evaluate the literature and examine the association between reduced CLABSI rates and central line bundle care implementation or current use. Methods A literature review was completed of nine critically appraised articles from the years 2010-2021. The association of the use of central line bundles and CLABSI rates was examined. These relationships were investigated to determine if the adherence to a central line bundle directly reduced the number of CLABSI rates in critically ill adult patients. A summary evaluation table was composed to determine the associations related to the implementation or current central line bundle care use. Results Of the study sample (N=9), all but one demonstrated a significant decrease in CLABSI rates when a central line bundle was in place. A trend towards reducing CLABSI was noted in the remaining article, a randomized controlled study, but the results were not significantly different. In all the other studies, a meta-analysis, randomized controlled trial, control trial, cohort or case-control studies, and quality improvement project, there was a significant improvement in CLABSI rates when utilizing a central line bundle. The extensive use of different levels of evidence provided an excellent synopsis that implementing a central line bundle care would directly affect decreasing CLABSI rates. Implications for Nursing Practice Results provided in this scoping review afforded the authors a diverse level of evidence that using a central line bundle has a direct outcome on reducing CLABSI rates. This practice can be implemented within the hospital setting as suggested by the literature review to prevent or reduce CLABSI rates. Implementing a standard central line bundle care hospital-wide helps avoid this hospital-acquired infection.

До бібліографії